Low-molecular-weight heparin vs. unfract
β
Maria Borentain; Gilles Montalescot; Anissa Bouzamondo; RΓ©mi Choussat; Jean-SΓ©ba
π
Article
π
2005
π
John Wiley and Sons
π
English
β 99 KB
## Abstract This metaβanalysis assessed the rates of the efficacy and safety endpoints with intravenous lowβmolecularβweight heparin (LMWH) compared with unfractionated heparin (UFH) in patients undergoing percutaneous coronary intervention (PCI). Subcutaneous LMWH has compared favorably with UFH,